Biotie names Chris Piggott chief business officer
This article was originally published in Scrip
Executive Summary
Biotie Therapies (Finland) has named Chris Piggott chief business officer and member of the management team, effective June 1st. He replaces Kai Lähdesmäki, formerly vice-president of business development, who retired from the company in 2007 but continues to serve as an advisor. Mr Piggott spent more than 25 years at Sanofi-Aventis and its predecessor companies, including Aventis Pharma, Marion Merrell Dow and Hoechst Marion Roussel.